Engineers Gate Manager LP
- SEC CIK
- 0001620220
- Latest filing
- Aug 14, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by Engineers Gate Manager LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q2 2026)
- 84,728
- Value
- $1.43M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 84,728 | $1.43M | <0.1% | −35,628−29.6% | Reduced | Holders |
| Q1 2026 | 120,356 | $1.54M | <0.1% | +37,305+44.9% | Added | Holders |
| Q4 2025 | 83,051 | $746.6K | <0.1% | −15,238−15.5% | Reduced | Holders |
| Q3 2025 | 98,289 | $1.70M | <0.1% | −34,725−26.1% | Reduced | Holders |
| Q2 2025 | 133,014 | $1.25M | <0.1% | +8,450+6.8% | Added | Holders |
| Q1 2025 | 124,564 | $885.6K | <0.1% | −23,603−15.9% | Reduced | Holders |
| Q4 2024 | 148,167 | $1.73M | <0.1% | +96,410+186.3% | Added | Holders |
| Q3 2024 | 51,757 | $1.06M | <0.1% | −9,771−15.9% | Reduced | Holders |
| Q2 2024 | 61,528 | $1.38M | <0.1% | +61,528 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −23,349−100.0% | Sold out | Holders |
| Q3 2023 | 23,349 | $738.3K | <0.1% | +16,143+224.0% | Added | Holders |
| Q2 2023 | 7,206 | $293.9K | <0.1% | −37,881−84.0% | Reduced | Holders |
| Q1 2023 | 45,087 | $1.68M | 0.1% | +6,520+16.9% | Added | Holders |
| Q4 2022 | 38,567 | $1.35M | 0.1% | +10,109+35.5% | Added | Holders |
| Q3 2022 | 28,458 | $1.59M | 0.1% | +28,458 | New | Holders |